۱۶ شهریور ۱۴۰۵ --:--
فوری
دلار آمریکا ۲۲۲,۴۰۰ ▼ ۱.۸۵٪ یورو ۲۵۹,۴۰۰ ▼ ۱.۷۴٪ طلای ۱۸ عیار ۲۳,۲۹۳,۱۰۰ ▼ ۱.۳۶٪ سکه امامی ۲۲۸,۶۳۱,۳۰۰ ▼ ۱.۶۸٪ بیت‌کوین ۱۷,۷۵۶,۰۰۰,۴۰۰ ▼ ۱.۷۳٪ بازار ›
Hemophiliac Patients at Risk; The Alarming Voice of the Hemophilia Association
Health

Hemophiliac Patients at Risk; The Alarming Voice of the Hemophilia Association

توسط بیژن اعتماد ۱۵ شهریور ۱۴۰۵ ۲ دقیقه زمان مطالعه ۳۱,۴۰۲

In an alarming warning, the Hemophilia Association has announced that more than four thousand hemophiliac patients in the country are in serious danger. This concerning situation not only harms the health of these patients but also indicates serious weaknesses in the treatment and support system for special patients.

Treatment Challenges for Hemophiliac Patients

Hemophilia is one of the bleeding disorders that requires specific and continuous treatments. However, hemophiliac patients in Iran face numerous problems, including limited access to necessary medications and medical services. These shortages are particularly felt in a situation where the country's economic crisis has imposed greater pressures on the health sector.

Many patients are facing serious risks due to a lack of access to essential medications. Meanwhile, the Hemophilia Association is trying to draw the attention of officials to the situation of these patients by holding meetings and awareness campaigns. But are these efforts enough?

Need for Immediate Action

The Hemophilia Association emphasizes that there is a need for immediate and effective actions to improve the conditions of hemophiliac patients. These actions should include securing necessary medications, improving medical services, and also providing financial support to patients. Otherwise, there will be serious risks to the health of these patients.

Ultimately, this issue not only concerns the health of hemophiliac patients but also reflects major failures in the country's health care system. Will officials pay attention to these warnings? Or should we wait for a larger disaster to occur?